1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 6 USDMF, 3 CEP/COS, 3 EU WC, 2 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers, 4 FDA Orange Book, 1 Europe, 4 Canada, 2 South Africa, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 9 Gangwal Healthcare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 DFE Pharma, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 10 Kerry, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 13 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

32 Fillers, Diluents & Binders, 21 Direct Compression, 12 Co-Processed Excipients, 10 Thickeners and Stabilizers, 9 Disintegrants & Superdisintegrants, 7 Granulation, 6 Lubricants & Glidants, 5 Taste Masking, 5 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 3 Coating Systems & Additives, 1 Film Formers & Plasticizers, 1 Rheology Modifiers